Blue Barn Wealth LLC Grows Stock Position in Haleon plc (NYSE:HLN)

Blue Barn Wealth LLC grew its position in shares of Haleon plc (NYSE:HLN) by 7.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,858 shares of the company’s stock after purchasing an additional 1,425 shares during the period. Blue Barn Wealth LLC’s holdings in Haleon were worth $172,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HLN. Bank of New York Mellon Corp increased its stake in Haleon by 71.3% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,495,001 shares of the company’s stock worth $12,453,000 after buying an additional 622,041 shares during the period. Brown Advisory Inc. increased its position in shares of Haleon by 9.8% during the third quarter. Brown Advisory Inc. now owns 36,323 shares of the company’s stock worth $303,000 after acquiring an additional 3,233 shares during the last quarter. Park Avenue Securities LLC lifted its stake in shares of Haleon by 12.8% in the third quarter. Park Avenue Securities LLC now owns 91,880 shares of the company’s stock worth $765,000 after acquiring an additional 10,431 shares in the last quarter. Keel Point LLC acquired a new position in shares of Haleon in the third quarter worth about $98,000. Finally, First Horizon Advisors Inc. boosted its holdings in Haleon by 53.4% in the third quarter. First Horizon Advisors Inc. now owns 14,478 shares of the company’s stock valued at $121,000 after purchasing an additional 5,038 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HLN has been the topic of a number of recent analyst reports. HSBC assumed coverage on Haleon in a research report on Wednesday, April 17th. They issued a “buy” rating on the stock. Argus reaffirmed a “buy” rating on shares of Haleon in a report on Tuesday, March 26th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Haleon Stock Up 1.1 %

Haleon stock traded up $0.09 during midday trading on Tuesday, hitting $8.33. The stock had a trading volume of 5,294,188 shares, compared to its average volume of 5,482,099. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53. The business has a fifty day moving average price of $8.33 and a 200 day moving average price of $8.29. Haleon plc has a 12 month low of $7.70 and a 12 month high of $8.98. The stock has a market cap of $38.04 billion, a P/E ratio of 27.48, a P/E/G ratio of 2.19 and a beta of 0.28.

Haleon Dividend Announcement

The company also recently disclosed a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be paid a dividend of $0.1064 per share. This represents a yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon’s dividend payout ratio (DPR) is presently 70.00%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.